LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
47.10
-0.16 (-0.34%)
Sep 1, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $1.52 billion as of September 2, 2026.
Market Cap
1.52B
Enterprise Value
1.20B
1-Year Change
n/a
Ranking
Category
Stock Price
$47.10
ChartMarket Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $1.52B, an increase of 403.95%. That is a compound annual growth rate of 427.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.52B | 169.80% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalyn Pharma | 1.56B |
| Bicara Therapeutics | 1.55B |
| Innoviva | 1.52B |
| Absci | 1.52B |
| Tyra Biosciences | 1.51B |
| Ascentage Pharma Group International | 1.51B |
| Apnimed | 1.49B |
| ArriVent BioPharma | 1.49B |